{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:29:09Z","timestamp":1778920149175,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T16:23:07Z","timestamp":1536423787000},"page":"246-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center\u00a0study"],"prefix":"10.1016","volume":"13","author":[{"given":"Herath Mudiyanselage Meththananda","family":"Herath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iroshani","family":"Kodikara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilak Priyantha","family":"Weerarathna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayani","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.dsx.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4254\/wjh.v7.i11.1450","article-title":"Non-alcoholic fatty liver disease in 2015","volume":"7","author":"Ahmed","year":"2015","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.dsx.2018.09.002_bib2","first-page":"101","article-title":"Fatty liver disease in diabetes mellitus","volume":"4","author":"Bhatt","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"10.1016\/j.dsx.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1016\/j.dsx.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american association for the study of liver diseases, american college of gastroenterology, and the american gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"9","key":"10.1016\/j.dsx.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabet Med : J Br Diabet Assoc"},{"issue":"3","key":"10.1016\/j.dsx.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1756-0500-4-513","article-title":"Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka","volume":"4","author":"Pinidiyapathirage","year":"2011","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.dsx.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5005\/jp-journals-10018-1217","article-title":"Liver disease in Sri Lanka","volume":"7","author":"W","year":"2017","journal-title":"Euroasian J Hepato-Gastroenterol"},{"issue":"3","key":"10.1016\/j.dsx.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.dsx.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2214\/AJR.07.2052","article-title":"Nonalcoholic fatty liver disease","volume":"190","author":"Lall","year":"2008","journal-title":"AJR. Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.dsx.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1746.2010.06528.x","article-title":"Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease","volume":"26","author":"Manchanayake","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.dsx.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","article-title":"Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dsx.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/gast.2001.27126","article-title":"Nonalcoholic steatohepatitis","volume":"121","author":"Reid","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dsx.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.dsx.2018.09.002_bib16","series-title":"Laboratory procedures used for the third national health and nutrition examination survey (NHANES III), 1988-1994","author":"Gunter","year":"1996"},{"key":"10.1016\/j.dsx.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.11152\/mu.2013.2066.151.hlv1qmu2","article-title":"Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease","volume":"15","author":"von Volkmann","year":"2013","journal-title":"Med Ultrason"},{"key":"10.1016\/j.dsx.2018.09.002_bib19","first-page":"215","article-title":"Relationship between serum uric acid and nonalcoholic fatty liver in patients with type 2 diabetes","volume":"28","author":"Li","year":"2012","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00508-014-0530-8","article-title":"Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients","volume":"26","author":"Sima","year":"2014","journal-title":"Wien Klin Wochenschr"},{"issue":"05","key":"10.1016\/j.dsx.2018.09.002_bib21","first-page":"04","article-title":"Prevalence of non alcoholic fatty liver disease and its association with diabetic nephropathy in patients with type 2 diabetes mellitus","author":"Heidari","year":"2017","journal-title":"J\u00a0Clin Diagn Res : J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.dsx.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"issue":"1 Pt 1","key":"10.1016\/j.dsx.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"22","key":"10.1016\/j.dsx.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.dsx.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of NAFLD and NASH","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.dsx.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1016\/j.dsx.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"LaBrecque","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"39","key":"10.1016\/j.dsx.2018.09.002_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.dsx.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2017.12.001","article-title":"Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes","volume":"16","author":"Bril","year":"2018","journal-title":"Clin Gastroenterol Hepatol :Offic Clin Prac J Am Gastroenterol Assoc"},{"issue":"5","key":"10.1016\/j.dsx.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118303801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118303801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:01:20Z","timestamp":1571875280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118303801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118303801"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.09.002","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center\u00a0study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}